Response to Tregs in Innate Immunity Receptor LRP1 (CD91) and Tregs in Periferic Blood Mononuclear Cells in Patients With Non-segmentary Vitiligo

clinical trial

Details

Instance of: clinical trial
Start time: 27 October 2015
End time: 13 September 2016
Country: Spain
Main subject: vitiligo
maximum age: 65
minimum age: 18
number of participants: 28
research site: Nou Hospital de Sant Pau
study type: observational study
title: Response to Tregs in Innate Immunity Receptor LRP1 (CD91) and Tregs in Periferic Blood Mononuclear Cells in Patients With Non-segmentary Vitiligo

Nothing in the MetaHistoryBook collection references this item yet.